Company profile for Faraday Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Faraday Pharmaceuticals® is a biopharmaceutical company pioneering the use of specific, reduced forms of natural elements — elemental reducing agents — to improve quality of life after acute, critical illness.While life expectancy has increased, so has the number of years that people live in poor health. A major contributor to decreased quality of life is associated with muscle loss following illnesses such as a heart att...
Faraday Pharmaceuticals® is a biopharmaceutical company pioneering the use of specific, reduced forms of natural elements — elemental reducing agents — to improve quality of life after acute, critical illness.While life expectancy has increased, so has the number of years that people live in poor health. A major contributor to decreased quality of life is associated with muscle loss following illnesses such as a heart attack or other emergency health crises.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
1616 Eastlake Ave E, Suite 560 Seattle, WA 98102
Telephone
Telephone
(206) 492-5310
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/09/11/3148759/0/en/Faraday-Pharmaceuticals-to-Participate-in-Upcoming-Investor-Events.html

GLOBENEWSWIRE
11 Sep 2025

https://www.globenewswire.com/news-release/2025/04/24/3067833/0/en/Faraday-Pharmaceuticals-to-Host-Satellite-Symposium-at-SCAI-2025-on-Exploring-New-Frontiers-in-Reducing-Ischemia-Reperfusion-Injury.html

GLOBENEWSWIRE
24 Apr 2025

https://www.globenewswire.com/news-release/2025/02/05/3021326/0/en/Faraday-Pharmaceuticals-to-Present-at-Oppenheimer-s-35th-Annual-Healthcare-Life-Sciences-Conference.html

GLOBENEWSWIRE
05 Feb 2025

https://www.globenewswire.com/news-release/2024/11/06/2975943/0/en/Faraday-Pharmaceuticals-to-Participate-in-Jefferies-London-Healthcare-Conference.html

GLOBENEWSWIRE
06 Nov 2024

https://www.globenewswire.com/news-release/2024/07/16/2914060/0/en/Faraday-Pharmaceuticals-to-Host-KOL-Webinar-on-the-Unmet-Need-in-the-Prevention-of-Ischemia-Reperfusion-Injury-in-Acute-STEMI.html

GLOBENEWSWIRE
16 Jul 2024

https://www.globenewswire.com/news-release/2024/06/11/2896797/0/en/Faraday-Pharmaceuticals-Announces-Completion-of-Enrollment-in-Pivotal-Phase-3-Iocyte-AMI-3-Trial-of-FDY-5301.html

GLOBENEWSWIRE
11 Jun 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty